跳至主要内容
临床试验/jRCT2031220338
jRCT2031220338招募中不适用

A long-term study of RBM-007 in children with achondroplasia

RIBOMIC Inc.0 个研究点目标入组 12 人开始时间: 2023年12月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
RIBOMIC Inc.
入组人数
12
主要终点
height growth velocity

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized Controlled Trial
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
5age old over 至 14age old under(—)
性别
All

入选标准

  • (1) Has completed the early phase II study, has completed the safety and efficacy evaluation (height growth velocity, etc.) by Investigator, and has been judged to have no safety issues
  • (2) Able to obtain written informed consent from surrogate decision maker (parents, relatives or legal representative) before study entry
  • Able to obtain written informed assent from the patient after explaining the contents of this study in the assent document (if possible)
  • (3) Able to perform all the tests and administration of investigational product described in the protocol, judged by Investigator

排除标准

  • (1) Inadequate as a patient for this study based on examinations, observations, etc. at the end of the early phase II study
  • (2) Highly likely to be unable to complete this study due to poor compliance treated with RBM-007 or poor implementation of regular examinations and observation items, judged by the Investigator
  • (3) Diagnosed with a closed growth plate in the examination at the end of the early phase II study
  • (4) Has a positive pregnancy test at the end of the early phase II study (only female patients)
  • (5) Inadequate as a patient for this study for any other reason than above, considered by the Investigator

结局指标

主要结局

height growth velocity

Comparison of height growth velocity in the observational study and height growth velocity after the early phase II study entry

serum ALP and NT-proCNP

Change in serum ALP and NT-proCNP

body weight, head circumference and chest circumference

Change in body weight, head circumference and chest circumference

BMI

Change in BMI

body proportion ratios

Change in body proportion ratios (ratio of upper arm length to forearm length, ratio of thigh length to lower leg length, ratio of arm span to height)

elbow and hip joints

Condition of the elbow and hip joints based on clinical findings

bone age

Bone age

morphological shape of the femoral growth plate

Morphological shape of the femoral growth plate

Tanner Staging Classification

Tanner Staging Classification

adverse event

Adverse event

次要结局

未报告次要终点

研究者

发起方
RIBOMIC Inc.

相似试验